The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126152903 12615290 3 F 201106 20160908 20160802 20160913 EXP PT-JNJFOC-20160724287 JANSSEN ANDRADE P, LOPES S, COELHO R, TERROSO G, LAGE J, MACEDO G. SQUAMOUS CELL CARCINOMA ARISING FROM A PRESACRAL CYST IN A PATIENT WITH ULCERATIVE COLITIS UNDER AZATHIOPRINE AND INFLIXIMAB: FIRST CASE REPORT. INT J COLORECTAL DIS 2016;31 (8):1509 - 10. 58.71 YR A F Y 0.00000 20160913 MD PT PT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126152903 12615290 1 PS INFLIXIMAB, RECOMBINANT INFLIXIMAB 1 Intravenous (not otherwise specified) Y N 103772 5 MG/KG LYOPHILIZED POWDER
126152903 12615290 2 SS AZATHIOPRINE. AZATHIOPRINE 1 Oral U 0 2.2 MG/KG UNSPECIFIED
126152903 12615290 3 SS MESALAZINE MESALAMINE 1 Oral U 0 3 G UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126152903 12615290 1 Colitis ulcerative
126152903 12615290 2 Colitis ulcerative
126152903 12615290 3 Colitis ulcerative

Outcome of event

Event ID CASEID OUTC COD
126152903 12615290 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126152903 12615290 Off label use
126152903 12615290 Product use issue
126152903 12615290 Squamous cell carcinoma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126152903 12615290 1 201106 201412 0
126152903 12615290 2 200604 0
126152903 12615290 3 200604 0